DrugPatentWatch Database Preview
Email this page to a colleague
« Back to Dashboard
Plinabulin is an investigational drug.
There have been 9 clinical trials for Plinabulin. The most recent clinical trial was a Phase 2 trial, which was initiated on June 1st 2016.
The most common disease conditions in clinical trials are Lung Neoplasms, Carcinoma, Non-Small-Cell Lung, and Neutropenia. The leading clinical trial sponsors are BeyondSpring Pharmaceuticals Inc., Jyoti Malhotra, and ICON plc.
There are sixty-three US patents protecting this investigational drug and four hundred and three international patents.
Recent Clinical Trials for Plinabulin
|Plinabulin in Combination With Radiation/Immunotherapy in Patients With Select Advanced Cancers After Progression on PD-1 or PD-L1 Targeted Antibodies||M.D. Anderson Cancer Center||Phase 1/Phase 2|
|A Phase I/II Study of Nivolumab, Ipilimumab and Plinabulin in Patients With Recurrent Small Cell Lung Cancer||Jyoti Malhotra||Phase 1/Phase 2|
|Plinabulin iv Solution in Prevention of TAC Induced Neutropenia||BeyondSpring Pharmaceuticals Inc.||Phase 2|
Top disease conditions for Plinabulin
Top clinical trial sponsors for Plinabulin
|Drugname||Patent Number||Patent Title||Patent Assignee||Estimated Expiration|
|Plinabulin||Get Started Free||Pharmaceutical compositions||Momenta Pharmaceuticals, Inc. (Cambridge, MA)||Get Started Free|
|Plinabulin||Get Started Free||Method of treating a brain tumor||BeyondSpring Pharmaceuticals, Inc. (New York, NY)||Get Started Free|
|Plinabulin||Get Started Free||Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof||Amgen Fremont Inc. (Fremont, CA)||Get Started Free|
|Plinabulin||Get Started Free||Controlled release dosage form||TRIASTEK, INC. (Nanjing, CN)||Get Started Free|
|Plinabulin||Get Started Free||Nanoparticle formulations for delivering multiple therapeutic agents||AMRITA VISHWA VIDYAPEETHAM (Kochi, Kerala, unknown)||Get Started Free|
|Plinabulin||Get Started Free||Plinabulin compositions||BeyondSpring Pharmaceuticals, Inc. (New York, NY)||Get Started Free|
|>Drugname||>Patent Number||>Patent Title||>Patent Assignee||>Estimated Expiration|
|Drugname||Country||Document Number||Estimated Expiration||Related US Patent|
|Plinabulin||Australia||AU2014274377||2033-05-28||Get Started Free|
|Plinabulin||Canada||CA2910837||2033-05-28||Get Started Free|
|Plinabulin||European Patent Office||EP3003324||2033-05-28||Get Started Free|
|Plinabulin||Japan||JP2016520613||2033-05-28||Get Started Free|
|Plinabulin||World Intellectual Property Organization (WIPO)||WO2014193818||2033-05-28||Get Started Free|
|Plinabulin||Australia||AU2016229295||2035-03-06||Get Started Free|
|>Drugname||>Country||>Document Number||>Estimated Expiration||>Related US Patent|